Australia Fast-Tracks Over 40 COVID-19 Tests; Concern Emerges Over Sensitivity Claims
The country's Therapeutic Goods Administration has explained how sponsors can apply for expedited approval of tests for COVID-19 and what special conditions apply. Meanwhile, post-market reviews of two approved serology-based COVID-19 point-of-care tests suggest they are not as sensitive as their manufacturers had claimed.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.